主页 / 资源 / 按需随选的网络研讨会 / 新冠肺炎期间管理临床试验和监管提交策略的注意事项
新冠肺炎期间管理临床试验和监管提交策略的注意事项
Tue, April 28th
按需随选的网络研讨会

COVID-19 has the potential to negatively impact critical activities such as patient recruitment, patient safety and ensuring data integrity. Thus, clinical developers should review their planned regulatory filing strategies to determine if modifications are required. Attend this webinar to learn mitigation strategies and best practices that you can begin implementing now.

Speakers:
Demetrius Carter, SVP Services Operations & Regulatory Services
Elaine B. Taylor, VP, Regulatory Strategy and Policy

返回顶部
Powered by Translations.com GlobalLink OneLink Software